Who
B. Kristine Johnson
Director
Company insider
Files Form 4 as: Director, ClearPoint Neuro; Director, AtriCure; Director, Paragon 28; Director, ViewRay; Director, Piper Sandler Companies; Director, Spectranetics.
In numbers
- Trades disclosed
- 112
- Buys
- 6
- Sells
- 5
- Bought
- $373K
- Sold
- $409K
- Companies
- 6
- Companies where not an officer
- 6
- First trade
- 2 May 2006
- Last trade
- 21 May 2026
- Last filed
- 26 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 26 May 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code A | —12,820 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code A | —12,820 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code M | —12,417 | filing |
| 19 May 2026filed 21 May 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code M | —12,417 | filing |
| 19 May 2026filed 21 May 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code M | —12,417 | filing |
| 19 May 2026filed 21 May 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code M | —12,417 | filing |
| 18 May 2026filed 20 May 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —6,144 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —6,144 at $0.00 | filing |
| 22 May 2025filed 23 May 2025 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code A | —12,417 at $0.00 | filing |
| 19 May 2025filed 21 May 2025 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —5,401 at $0.00 | filing |
| 16 May 2025filed 19 May 2025 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code M | —21,093 | filing |
| 16 May 2025filed 19 May 2025 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code M | —21,093 | filing |
| 21 Apr 2025filed 21 Apr 2025 | Paragon 28 | SEC FORM 4 Code D | —47,347 | filing |
| 17 May 2024filed 21 May 2024 | Paragon 28 | SEC FORM 4 Code A | —15,906 at $0.00 | filing |
| 16 May 2024filed 17 May 2024 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code A | —21,093 at $0.00 | filing |
| 14 May 2024filed 15 May 2024 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code M | —17,153 at $0.00 | filing |
| 14 May 2024filed 15 May 2024 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code M | —17,153 | filing |
| 13 May 2024filed 14 May 2024 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —7,788 at $0.00 | filing |
| 21 Jul 2023filed 24 Jul 2023 | ViewRay | SEC FORM 4 Sold | $1,53530,702 at $0.05 | filing |
| 18 Jul 2023filed 20 Jul 2023 | ViewRay | SEC FORM 4 Sold | $5,57479,622 at $0.07 | filing |
News
Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)ATRC · tickerreport.com · 18 Oct 2026Piper Sandler Companies (NYSE:PIPR) vs. DeFi Technologies (NASDAQ:DEFT) Critical ReviewPIPR · dailypolitical.com · 17 Oct 2026Financial Comparison: Piper Sandler Companies (NYSE:PIPR) and Eagle Point Credit (NYSE:ECC)PIPR · themarketsdaily.com · 14 Oct 2026
0 headlines in the last 90 days name B. Kristine Johnson; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.